{
  "locale": "en",
  "category": "other",
  "generatedAt": "2025-12-27T13:00:44.805Z",
  "count": 10,
  "diseases": [
    {
      "id": "sindrome-fragilidade",
      "titulo": "Frailty Syndrome",
      "ciap2": [
        "A04"
      ],
      "cid10": [
        "R54"
      ],
      "cid11": [
        "MG2A"
      ],
      "categoria": "other",
      "doid": "DOID:0080429",
      "snomedCT": "248279007",
      "meshId": "D000073496",
      "umlsCui": "C0424594",
      "quickView": {
        "definicao": "Geriatric syndrome of increased vulnerability to stressors due to a decline in physiological reserves. Prevalence of 10-15% in individuals >65 years.",
        "criteriosDiagnosticos": [
          "Fried phenotype: ≥3 criteria = frail, 1-2 = pre-frail",
          "Unintentional weight loss >4.5 kg/year",
          "Self-reported exhaustion",
          "Low physical activity",
          "Slow gait speed",
          "Weakness (grip strength)"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Multicomponent exercise (resistance + balance)",
            "Protein nutritional intervention",
            "Comprehensive geriatric assessment"
          ],
          "farmacologico": [
            "Vitamin D if deficient",
            "Medication review and deprescribing"
          ]
        },
        "redFlags": [
          "Recurrent falls",
          "Significant weight loss",
          "Frequent hospitalizations",
          "Rapid functional decline"
        ]
      },
      "medicamentos": [
        "vitamina-d"
      ],
      "protocolos": [],
      "calculadoras": []
    },
    {
      "id": "incontinencia-urinaria-idoso",
      "titulo": "Urinary Incontinence in the Elderly",
      "ciap2": [
        "U04"
      ],
      "cid10": [
        "N39.4"
      ],
      "cid11": [
        "MF50"
      ],
      "categoria": "other",
      "doid": "DOID:13580",
      "snomedCT": "165232002",
      "meshId": "D014549",
      "umlsCui": "C0042024",
      "quickView": {
        "definicao": "Involuntary loss of urine causing social or hygienic impact. Affects 30-50% of elderly individuals in the community.",
        "criteriosDiagnosticos": [
          "Identify type: urgency, stress, mixed, functional",
          "Bladder diary",
          "Positive stress test",
          "Post-void residual"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Kegel exercises (pelvic floor)",
            "Bladder training",
            "Scheduled voiding",
            "Reduce caffeine intake"
          ],
          "farmacologico": [
            "Oxybutynin or Tolterodine (urgency)",
            "Mirabegron (alternative)",
            "Caution with anticholinergics in the elderly"
          ]
        },
        "redFlags": [
          "Hematuria",
          "Pelvic pain",
          "Recurrent urinary tract infection",
          "Urinary retention"
        ]
      },
      "medicamentos": [],
      "protocolos": [],
      "calculadoras": []
    },
    {
      "id": "quedas-idoso",
      "titulo": "Fall Syndrome in the Elderly",
      "ciap2": [
        "A29"
      ],
      "cid10": [
        "W19"
      ],
      "cid11": [
        "NE01"
      ],
      "categoria": "other",
      "doid": "DOID:14002",
      "snomedCT": "56307009",
      "meshId": "D000058",
      "umlsCui": "C0000921",
      "quickView": {
        "definicao": "Unintentional event of displacement to the ground. 30% of individuals >65 years fall annually. The leading cause of traumatic death in the elderly.",
        "criteriosDiagnosticos": [
          "≥2 falls in 12 months = high risk",
          "Timed Up and Go >12 seconds",
          "Detailed history of the fall",
          "Assessment of gait and balance"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Balance exercises (Tai Chi)",
            "Vision correction",
            "Environmental adaptation",
            "Appropriate footwear"
          ],
          "farmacologico": [
            "Vitamin D 800-1000IU/day",
            "Review sedatives and antihypertensives"
          ]
        },
        "redFlags": [
          "Fall with fracture",
          "Head injury",
          "Associated syncope",
          "Recurrent falls"
        ]
      },
      "medicamentos": [
        "vitamin-d"
      ],
      "protocolos": [],
      "calculadoras": []
    },
    {
      "id": "conjuntivite",
      "titulo": "Conjunctivitis",
      "ciap2": [
        "F70"
      ],
      "cid10": [
        "H10"
      ],
      "cid11": [
        "9A60"
      ],
      "categoria": "other",
      "doid": "DOID:6195",
      "snomedCT": "9826008",
      "meshId": "D003231",
      "umlsCui": "C0009763",
      "quickView": {
        "definicao": "Inflammation of the conjunctiva. Viral (most common), bacterial, or allergic. Highly contagious if infectious.",
        "criteriosDiagnosticos": [
          "Conjunctival hyperemia",
          "Discharge (watery=viral, purulent=bacterial)",
          "Pruritus (allergic)",
          "Foreign body sensation"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Cold compresses",
            "Hand hygiene",
            "Avoid contact with others"
          ],
          "farmacologico": [
            "Viral: self-limiting 7-14 days",
            "Bacterial: Ciprofloxacin eye drops 1 drop 4 times daily for 7 days",
            "Allergic: Antihistamine eye drops"
          ]
        },
        "redFlags": [
          "Severe ocular pain",
          "Photophobia",
          "Reduced visual acuity",
          "Corneal opacity"
        ]
      },
      "medicamentos": [],
      "protocolos": [],
      "calculadoras": []
    },
    {
      "id": "olho-seco",
      "titulo": "Dry Eye Syndrome",
      "ciap2": [
        "F13"
      ],
      "cid10": [
        "H04.1"
      ],
      "cid11": [
        "9A0A"
      ],
      "categoria": "other",
      "doid": "DOID:12895",
      "snomedCT": "302896008",
      "meshId": "D015352",
      "umlsCui": "C0013238",
      "quickView": {
        "definicao": "Multifactorial disease of the ocular surface with instability of the tear film. Prevalence increases with age and screen use.",
        "criteriosDiagnosticos": [
          "Sensation of sand in the eyes",
          "Burning",
          "Intermittent blurred vision",
          "Eye fatigue",
          "Reflex tearing"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Frequent breaks from screen use (20-20-20 rule)",
            "Humidifier",
            "Avoid direct air conditioning"
          ],
          "farmacologico": [
            "Preservative-free artificial tears 4-6 times/day",
            "Lubricating gel at night"
          ]
        },
        "redFlags": [
          "Severe pain",
          "Vision loss",
          "No response to treatment"
        ]
      },
      "medicamentos": [],
      "protocolos": [],
      "calculadoras": []
    },
    {
      "id": "estomatite-aftosa",
      "titulo": "Recurrent Aphthous Stomatitis",
      "sinonimos": [
        "Oral ulcers",
        "Oral aphthae"
      ],
      "ciap2": [
        "D82"
      ],
      "cid10": [
        "K12.0"
      ],
      "cid11": [
        "DA01.0"
      ],
      "categoria": "other",
      "doid": "DOID:10581",
      "snomedCT": "54081009",
      "meshId": "D013281",
      "umlsCui": "C0038362",
      "hpo": [
        "HP:0000160"
      ],
      "tags": [
        "oral",
        "common",
        "recurrent"
      ],
      "quickView": {
        "definicao": "Recurrent oral ulcers. Painful aphthae. Etiology not fully understood. May be associated with nutritional deficiencies.",
        "criteriosDiagnosticos": [
          "Recurrent oral ulcers",
          "Localized pain",
          "Duration of weeks",
          "Spontaneous healing"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Avoid acidic/spicy foods",
            "Adequate oral hygiene",
            "Supplementation: Iron, B12, Folic acid if deficient"
          ],
          "farmacologico": [
            "Topical corticosteroids",
            "Topical anesthetics",
            "Oral antiseptics"
          ]
        },
        "redFlags": [
          "Genital ulcers (Behçet's disease)",
          "Multiple large ulcers",
          "No healing"
        ]
      },
      "medicamentos": [],
      "protocolos": [],
      "calculadoras": []
    },
    {
      "id": "cerume-impactado",
      "titulo": "Impacted Cerumen",
      "sinonimos": [
        "Cerumen Plug"
      ],
      "ciap2": [
        "H82"
      ],
      "cid10": [
        "H61.2"
      ],
      "cid11": [
        "AB30.0"
      ],
      "categoria": "other",
      "doid": "DOID:14694",
      "snomedCT": "69695003",
      "meshId": "D002624",
      "umlsCui": "C0007783",
      "tags": [
        "otolaryngology",
        "common"
      ],
      "quickView": {
        "definicao": "Excessive accumulation of cerumen in the external auditory canal, causing obstruction and symptoms such as hearing loss and aural fullness.",
        "criteriosDiagnosticos": [
          "Hearing loss",
          "Aural fullness",
          "Otoscopy: obstructive cerumen",
          "May have itching",
          "May have mild ear pain"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Manual removal with a curette",
            "Irrigation with warm water",
            "Ceruminolytic drops: Cerumin or Hydrogen peroxide before removal"
          ],
          "farmacologico": [
            "Topical ceruminolytics for 3-5 days before removal"
          ]
        },
        "redFlags": [
          "Tympanic membrane perforation",
          "External ear infection",
          "Severe pain"
        ]
      },
      "medicamentos": [],
      "protocolos": [],
      "calculadoras": []
    },
    {
      "id": "anafilaxia",
      "titulo": "Anaphylaxis",
      "sinonimos": [
        "Anaphylactic Reaction",
        "Anaphylactic Shock",
        "Systemic Anaphylaxis"
      ],
      "doid": "DOID:5841",
      "snomedCT": "39579001",
      "meshId": "D000707",
      "umlsCui": "C0002792",
      "ciap2": [
        "A92"
      ],
      "cid10": [
        "T78.2",
        "T78.0",
        "T80.5",
        "T88.6"
      ],
      "cid11": [
        "4A84"
      ],
      "categoria": "other",
      "quickView": {
        "definicao": "Severe systemic hypersensitivity reaction, potentially fatal, with rapid onset after allergen exposure. Requires immediate recognition and treatment with adrenaline.",
        "criteriosDiagnosticos": [
          "CRITERION 1: Acute onset with skin/mucosal involvement + respiratory compromise OR hypotension",
          "CRITERION 2: ≥2 of the following after probable exposure: skin/mucosa, respiratory, hypotension, gastrointestinal symptoms",
          "CRITERION 3: Hypotension after known allergen",
          "Time: minutes to hours after exposure",
          "Common triggers: medications, foods, insects, latex"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "REMOVE ALLERGEN if possible",
            "Position patient (Trendelenburg if hypotensive)",
            "ABC - airway, oxygen",
            "Large-bore IV access",
            "Continuous monitoring"
          ],
          "farmacologico": [
            "ADRENALINE IM 0.3-0.5mg (0.01mg/kg) anterior thigh",
            "Repeat every 5-15min if needed",
            "0.9% NS 20mL/kg bolus if hypotensive",
            "Diphenhydramine 25-50mg IV (adjunct)",
            "Ranitidine 50mg IV (adjunct)",
            "Methylprednisolone 1-2mg/kg IV (to prevent biphasic reaction)"
          ]
        },
        "metasTerapeuticas": [
          "Hemodynamic stabilization",
          "Reversal of bronchospasm",
          "Prevention of biphasic reaction",
          "Identification of allergen"
        ],
        "examesIniciais": [
          "Serum tryptase (draw within 1h, repeat at 24h)",
          "ECG (if cardiovascular symptoms)",
          "Arterial blood gas (if severe dyspnea)",
          "Observation for 4-6h minimum"
        ],
        "redFlags": [
          "Severe stridor or wheezing (airway edema)",
          "Refractory hypotension to adrenaline",
          "Need for >2 doses of adrenaline",
          "Use of beta-blocker (attenuated response)",
          "Severe pre-existing asthma",
          "Biphasic reaction (recurrence within 1-72h)"
        ]
      },
      "fullContent": {
        "epidemiologia": {
          "prevalencia": "0.05-2% of the general population",
          "incidencia": "50-112 cases/100,000 person-years",
          "mortalidade": "0.5-1% of cases, higher in adolescents/young adults",
          "faixaEtaria": "Any age; foods more common in children, medications in adults",
          "fatoresRisco": [
            "History of anaphylaxis",
            "Asthma (especially poorly controlled)",
            "Systemic mastocytosis",
            "Use of beta-blockers or ACE inhibitors",
            "Post-prandial exercise",
            "Peanut/nut allergy (higher risk of fatality)"
          ],
          "citations": [
            {
              "refId": "wao-anaphylaxis-2020"
            }
          ]
        },
        "fisiopatologia": {
          "texto": "IgE-mediated (majority) or non-IgE reaction with massive degranulation of mast cells and basophils, releasing histamine, tryptase, leukotrienes, and prostaglandins. Causes vasodilation, increased vascular permeability, bronchoconstriction, and stimulation of nerve endings.",
          "citations": [
            {
              "refId": "eaaci-anaphylaxis-2021"
            }
          ]
        },
        "quadroClinico": {
          "sintomasPrincipais": [
            "Urticaria, pruritus, flushing",
            "Angioedema (lips, tongue, eyelids)",
            "Dyspnea, wheezing, stridor",
            "Abdominal pain, nausea, vomiting, diarrhea",
            "Dizziness, syncope",
            "Sense of impending doom"
          ],
          "sinaisExameFisico": [
            "Generalized urticaria",
            "Lip/tongue/uvula edema",
            "Wheezing, rhonchi, stridor",
            "Hypotension, tachycardia",
            "Altered level of consciousness",
            "Cyanosis"
          ],
          "formasClinicas": [
            "Uniphasic anaphylaxis (single episode)",
            "Biphasic anaphylaxis (recurrence within 1-72h)",
            "Protracted anaphylaxis (persistent symptoms)",
            "Exercise-induced anaphylaxis"
          ],
          "citations": [
            {
              "refId": "wao-anaphylaxis-2020"
            }
          ]
        },
        "diagnostico": {
          "criterios": [
            "WAO (World Allergy Organization) clinical criteria",
            "Rapid onset after exposure",
            "Response to adrenaline supports diagnosis"
          ],
          "diagnosticoDiferencial": [
            "Isolated urticaria/angioedema",
            "Asthma attack",
            "Vasovagal syncope",
            "Panic attack",
            "Carcinoid syndrome",
            "Systemic mastocytosis",
            "Septic shock"
          ],
          "examesLaboratoriais": [
            "Serum tryptase (peak at 1-2h)",
            "Plasma histamine (short half-life)",
            "Specific IgE later"
          ],
          "citations": [
            {
              "refId": "eaaci-anaphylaxis-2021"
            }
          ]
        },
        "tratamento": {
          "objetivos": [
            "Immediate stabilization",
            "Prevention of progression",
            "Prevention of biphasic reaction",
            "Education and secondary prevention"
          ],
          "naoFarmacologico": {
            "medidas": [
              "Remove trigger if possible",
              "Supine position with legs elevated",
              "Supplemental oxygen",
              "Large-bore IV access",
              "Prepare for intubation if airway edema"
            ],
            "citations": [
              {
                "refId": "wao-anaphylaxis-2020"
              }
            ]
          },
          "farmacologico": {
            "primeiraLinha": [
              {
                "classe": "Adrenaline",
                "medicamentos": [
                  "Adrenaline 1:1000 (1mg/mL)"
                ],
                "posologia": "0.3-0.5mg IM (0.01mg/kg in children, max 0.5mg)",
                "observacoes": "Anterior thigh. Repeat every 5-15min"
              }
            ],
            "segundaLinha": [
              {
                "classe": "H1 Antihistamine",
                "medicamentos": [
                  "Diphenhydramine 25-50mg IV",
                  "Promethazine 25mg IM"
                ],
                "observacoes": "Adjunct, does not replace adrenaline"
              },
              {
                "classe": "H2 Antihistamine",
                "medicamentos": [
                  "Ranitidine 50mg IV"
                ],
                "observacoes": "May help with cutaneous symptoms"
              },
              {
                "classe": "Corticosteroid",
                "medicamentos": [
                  "Methylprednisolone 1-2mg/kg IV",
                  "Hydrocortisone 200mg IV"
                ],
                "observacoes": "May prevent biphasic reaction, no immediate effect"
              },
              {
                "classe": "Bronchodilator",
                "medicamentos": [
                  "Salbutamol 4-8 puffs or nebulization"
                ],
                "observacoes": "If bronchospasm"
              }
            ],
            "situacoesEspeciais": [
              {
                "situacao": "Use of beta-blocker",
                "conduta": "Glucagon 1-5mg IV if refractory to adrenaline"
              },
              {
                "situacao": "Refractory shock",
                "conduta": "Adrenaline IV 0.1-0.5mcg/kg/min in BIC"
              }
            ],
            "citations": [
              {
                "refId": "eaaci-anaphylaxis-2021"
              }
            ]
          },
          "duracao": "Minimum observation 4-6h (up to 24h if severe or previous biphasic reaction)"
        },
        "acompanhamento": {
          "frequenciaConsultas": "Allergist follow-up 2-4 weeks post-discharge",
          "metasTerapeuticas": [
            "Identification of allergen",
            "Prescription of adrenaline auto-injector",
            "Patient and family education",
            "Written action plan"
          ],
          "criteriosEncaminhamento": [
            "All patients: Allergist for investigation",
            "Consider immunotherapy if insect venom",
            "Desensitization if essential medication"
          ],
          "citations": [
            {
              "refId": "wao-anaphylaxis-2020"
            }
          ]
        },
        "prevencao": {
          "primaria": [
            "Identification and avoidance of allergens",
            "Reading food labels",
            "Medical alerts in medical records"
          ],
          "secundaria": [
            "Carry adrenaline auto-injector always",
            "Medical alert bracelet",
            "Education of family and caregivers",
            "Written emergency plan"
          ],
          "citations": [
            {
              "refId": "eaaci-anaphylaxis-2021"
            }
          ]
        }
      },
      "protocolos": [
        "anafilaxia-emergencia",
        "choque-anafilatico"
      ],
      "medicamentos": [
        "adrenalina",
        "difenidramina",
        "metilprednisolona",
        "ranitidina"
      ],
      "calculadoras": [],
      "citations": [
        {
          "refId": "wao-anaphylaxis-2020"
        },
        {
          "refId": "eaaci-anaphylaxis-2021"
        },
        {
          "refId": "asbai-anafilaxia-2022"
        }
      ],
      "lastUpdate": "2024-12-23"
    },
    {
      "id": "intoxicacao-exogena",
      "titulo": "Acute Exogenous Intoxication",
      "sinonimos": [
        "Poisoning",
        "Drug intoxication",
        "Overdose",
        "Drug toxicity"
      ],
      "doid": "DOID:3571",
      "snomedCT": "75478009",
      "meshId": "D011041",
      "umlsCui": "C0032343",
      "ciap2": [
        "A84",
        "A86"
      ],
      "cid10": [
        "T36-T65",
        "T50.9",
        "X40-X49"
      ],
      "cid11": [
        "NE61"
      ],
      "categoria": "other",
      "quickView": {
        "definicao": "Exposure to toxic substances (medications, drugs, chemicals, poisonous plants, venomous animals) resulting in potentially severe clinical manifestations. Requires identification of the agent and specific treatment.",
        "criteriosDiagnosticos": [
          "History of exposure (intentional or accidental)",
          "Clinical presentation compatible (toxidrome)",
          "CLASSIC TOXIDROMES:",
          "Cholinergic: SLUDGE (salivation, lacrimation, urination, diarrhoea, gastrointestinal, vomiting) + miosis + bradycardia",
          "Anticholinergic: \"blind, red, dry, hot, mad\" + mydriasis + tachycardia",
          "Sympathomimetic: tachycardia, hypertension, mydriasis, hyperthermia, agitation",
          "Opioid: pinpoint miosis, respiratory depression, coma",
          "Sedative-hypnotic: central nervous system depression, hypotension, hypothermia"
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "ABC - airway is a priority",
            "Cutaneous/ocular decontamination if external exposure",
            "Continuous monitoring",
            "Intravenous access",
            "ECG (evaluate QRS, QTc)"
          ],
          "farmacologico": [
            "SPECIFIC ANTIDOTES (when available):",
            "Opioids: Naloxone 0.4-2mg IV (repeat up to 10mg)",
            "Benzodiazepines: Flumazenil 0.2-0.5mg IV (caution!)",
            "Organophosphates: Atropine 2-4mg IV + Pralidoxime",
            "Paracetamol: N-acetylcysteine",
            "Tricyclic antidepressants: Sodium bicarbonate if QRS>100ms",
            "Activated charcoal 1g/kg if <1h post-ingestion (no contraindications)"
          ]
        },
        "metasTerapeuticas": [
          "Patient stabilization",
          "Identification of the toxic agent",
          "Decontamination when indicated",
          "Administration of specific antidote",
          "Prevention of complications"
        ],
        "examesIniciais": [
          "Capillary glucose (ALWAYS)",
          "12-lead ECG",
          "Arterial blood gas",
          "Electrolytes (including Ca, Mg)",
          "Renal and liver function",
          "Complete blood count, coagulation profile",
          "Toxicology screen (urine)",
          "Specific serum levels if available (paracetamol, salicylate, lithium, digoxin)"
        ],
        "redFlags": [
          "Respiratory depression (RR<12)",
          "Arrhythmias (QRS>100ms, QTc>500ms)",
          "Seizures",
          "Refractory hypotension",
          "Malignant hyperthermia",
          "Rhabdomyolysis",
          "Altered level of consciousness"
        ]
      },
      "fullContent": {
        "epidemiologia": {
          "prevalencia": "~2.5 million exposures/year in the USA",
          "incidencia": "In Brazil: ~100,000 cases/year reported (underreported)",
          "mortalidade": "Varies by agent; opioids and pesticides have the highest mortality",
          "faixaEtaria": "Children <6 years: mostly accidental; Adolescents/adults: intentional",
          "fatoresRisco": [
            "Access to medications",
            "Psychiatric disorders",
            "Illicit drug use",
            "Agricultural work (pesticides)",
            "Young children (oral exploration)"
          ],
          "citations": [
            {
              "refId": "aapcc-annual-report-2022"
            }
          ]
        },
        "fisiopatologia": {
          "texto": "Varies by agent: binding to specific receptors, enzymatic inhibition, ionic channel alteration, direct cellular damage. Each toxidrome reflects the predominant mechanism of the involved agent.",
          "citations": [
            {
              "refId": "goldfrank-toxicology"
            }
          ]
        },
        "quadroClinico": {
          "sintomasPrincipais": [
            "Altered level of consciousness",
            "Nausea and vomiting",
            "Seizures",
            "Pupillary changes",
            "Body temperature changes",
            "Neuromuscular changes"
          ],
          "sinaisExameFisico": [
            "Pupillary size (miosis vs mydriasis)",
            "Sweating or dry mucous membranes",
            "Heart rate and rhythm",
            "Body temperature",
            "Mental status",
            "Bowel sounds (increased vs decreased)",
            "Characteristic odors"
          ],
          "formasClinicas": [
            "Cholinergic toxidrome (organophosphates, carbamates)",
            "Anticholinergic toxidrome (antihistamines, tricyclic antidepressants, scopolamine)",
            "Sympathomimetic toxidrome (cocaine, amphetamines)",
            "Opioid toxidrome (morphine, fentanyl, heroin)",
            "Sedative-hypnotic toxidrome (benzodiazepines, barbiturates)"
          ],
          "citations": [
            {
              "refId": "goldfrank-toxicology"
            }
          ]
        },
        "diagnostico": {
          "criterios": [
            "History of exposure",
            "Compatible toxidrome",
            "Exclusion of other causes",
            "Specific serum levels when available"
          ],
          "diagnosticoDiferencial": [
            "Hypoglycemia",
            "Stroke",
            "Metabolic encephalopathy",
            "Central nervous system infection",
            "Psychiatric disorders",
            "Head trauma"
          ],
          "examesLaboratoriais": [
            "Glucose",
            "Blood gas with lactate",
            "Electrolytes, osmolality",
            "Renal and liver function",
            "CK (rhabdomyolysis)",
            "Coagulation profile",
            "Toxicology screen",
            "Specific levels (paracetamol, salicylate, digoxin, lithium, etc.)"
          ],
          "examesImagem": [
            "Chest X-ray (aspiration)",
            "Abdominal X-ray (body packer)",
            "CT head if persistent altered sensorium"
          ],
          "citations": [
            {
              "refId": "sbpt-intoxicacoes-2021"
            }
          ]
        },
        "tratamento": {
          "objetivos": [
            "Clinical stabilization",
            "Decontamination",
            "Specific antidote",
            "Support of organ dysfunction",
            "Psychiatric evaluation (if intentional)"
          ],
          "naoFarmacologico": {
            "medidas": [
              "Endotracheal intubation if necessary",
              "Gastric lavage (contraindicated: corrosives, hydrocarbons, <1h)",
              "Activated charcoal (if <1h, adsorbable agent, protected airway)",
              "Whole bowel irrigation (body packer, Fe, Li, prolonged release)",
              "Hemodialysis (salicylates, methanol, ethylene glycol, lithium)"
            ],
            "citations": [
              {
                "refId": "goldfrank-toxicology"
              }
            ]
          },
          "farmacologico": {
            "primeiraLinha": [
              {
                "classe": "Antidotes",
                "medicamentos": [
                  "Naloxone (opioids)",
                  "Atropine (organophosphates)",
                  "N-acetylcysteine (paracetamol)",
                  "Flumazenil (BZD)",
                  "Sodium bicarbonate (tricyclic antidepressants)"
                ],
                "observacoes": "Use according to identified agent"
              }
            ],
            "situacoesEspeciais": [
              {
                "situacao": "Paracetamol",
                "conduta": "N-acetylcysteine if above treatment line on nomogram"
              },
              {
                "situacao": "Organophosphates",
                "conduta": "Atropine to dry secretions + Pralidoxime in the first 24-48h"
              },
              {
                "situacao": "Tricyclic antidepressants",
                "conduta": "Sodium bicarbonate 1-2mEq/kg if QRS>100ms"
              }
            ],
            "citations": [
              {
                "refId": "sbpt-intoxicacoes-2021"
              }
            ]
          },
          "duracao": "Minimum observation 6-24h depending on the agent; some require prolonged hospitalization"
        },
        "acompanhamento": {
          "frequenciaConsultas": "Depending on severity and agent",
          "metasTerapeuticas": [
            "Resolution of symptoms",
            "Normalization of laboratory values",
            "Psychiatric evaluation if intentional"
          ],
          "criteriosEncaminhamento": [
            "ICU if hemodynamic instability or respiratory depression",
            "Psychiatry if suicide attempt",
            "Poison control center for guidance (0800 722 6001 - CEATOX-SP)"
          ],
          "citations": [
            {
              "refId": "sbpt-intoxicacoes-2021"
            }
          ]
        },
        "prevencao": {
          "primaria": [
            "Safe storage of medications and chemicals",
            "Education on risks",
            "Child-resistant packaging"
          ],
          "secundaria": [
            "Early recognition",
            "Immediate contact with poison control center",
            "Evaluation and treatment of psychiatric disorders"
          ],
          "citations": [
            {
              "refId": "aapcc-annual-report-2022"
            }
          ]
        }
      },
      "protocolos": [
        "intoxicacao-aguda",
        "lavagem-gastrica",
        "carvao-ativado"
      ],
      "medicamentos": [
        "naloxona",
        "atropina",
        "n-acetilcisteina",
        "flumazenil"
      ],
      "calculadoras": [
        "nomograma-paracetamol"
      ],
      "citations": [
        {
          "refId": "goldfrank-toxicology"
        },
        {
          "refId": "sbpt-intoxicacoes-2021"
        },
        {
          "refId": "aapcc-annual-report-2022"
        }
      ],
      "lastUpdate": "2024-12-23"
    },
    {
      "id": "queimaduras",
      "titulo": "Burns",
      "sinonimos": [
        "Thermal burn",
        "Chemical burn",
        "Electrical burn",
        "Scald"
      ],
      "doid": "DOID:0080312",
      "snomedCT": "125666000",
      "meshId": "D002056",
      "umlsCui": "C0006434",
      "ciap2": [
        "S14"
      ],
      "cid10": [
        "T20-T32",
        "T30",
        "T31"
      ],
      "cid11": [
        "NB5"
      ],
      "categoria": "other",
      "quickView": {
        "definicao": "Tissue injury caused by thermal, chemical, electrical, or radioactive agents. Severity depends on extent (% TBSA), depth, and location. Major burns require volume resuscitation and specialized treatment.",
        "criteriosDiagnosticos": [
          "DEPTH:",
          "1st degree: erythema, pain, no blisters (epidermis)",
          "Superficial 2nd degree: blisters, wet base, very painful",
          "Deep 2nd degree: ruptured blisters, pale base, less painful",
          "3rd degree: necrosis, painless, white/black color",
          "",
          "EXTENT - Rule of Nines (adult):",
          "Head 9%, Each upper limb 9%, Anterior chest 18%, Posterior chest 18%, Each lower limb 18%, Perineum 1%",
          "Patient's palm = 1% TBSA"
        ],
        "classificacaoRisco": [
          {
            "nivel": "low",
            "criterios": [
              "<10% TBSA adult",
              "Superficial 2nd degree",
              "No face/hands/feet/perineum"
            ],
            "conduta": "Outpatient treatment"
          },
          {
            "nivel": "moderate",
            "criterios": [
              "10-20% TBSA",
              "Deep 2nd degree",
              "Elderly or child"
            ],
            "conduta": "Consider hospitalization"
          },
          {
            "nivel": "high",
            "criterios": [
              ">20% TBSA",
              "3rd degree >5%",
              "Face, hands, feet, genitals, joints",
              "Electrical, chemical, inhalation"
            ],
            "conduta": "Burn center"
          }
        ],
        "tratamentoPrimeiraLinha": {
          "naoFarmacologico": [
            "Cool with running water (10-20min) - DO NOT use ice",
            "Remove clothing and jewelry (if not adhered)",
            "Cover with clean/sterile dressing",
            "Elevate extremities",
            "Maintain body temperature (avoid hypothermia)"
          ],
          "farmacologico": [
            "VOLUME RESUSCITATION (Parkland):",
            "4mL x weight(kg) x %TBSA in the first 24h",
            "50% in the first 8h, 50% in the next 16h",
            "Goal: urine output 0.5-1mL/kg/h",
            "",
            "Analgesia: Morphine or Tramadol IV",
            "Tetanus prophylaxis",
            "DO NOT use routine prophylactic antibiotics",
            "Dressings with silver sulfadiazine (2nd/3rd degree)"
          ]
        },
        "metasTerapeuticas": [
          "Adequate volume resuscitation",
          "Pain control",
          "Infection prevention",
          "Function and aesthetic preservation",
          "Directed healing"
        ],
        "examesIniciais": [
          "Complete blood count, electrolytes, renal function",
          "Arterial blood gas (if inhalation)",
          "Carboxyhemoglobin (if fire in enclosed space)",
          "ECG (if electrical burn)",
          "CK (rhabdomyolysis in electrical burns)",
          "Chest X-ray (if inhalation suspected)"
        ],
        "redFlags": [
          "Airway burn (hoarseness, stridor, singed nasal hairs)",
          "Electrical burn (risk of arrhythmia and compartment syndrome)",
          "Chemical burn (continuous irrigation)",
          "Circumferential injury (compartment syndrome)",
          "TBSA >20% (hypovolemic shock)",
          "Extremes of age (<2 or >60 years)"
        ]
      },
      "fullContent": {
        "epidemiologia": {
          "prevalencia": "Millions of cases/year globally",
          "incidencia": "~1 million cases/year in Brazil",
          "mortalidade": "Depends on extent; >50% TBSA has high mortality",
          "faixaEtaria": "Small children (scalds) and adults (work)",
          "fatoresRisco": [
            "Unsafe home environment",
            "Risky work (industry, construction)",
            "Alcohol and drugs",
            "Epilepsy",
            "Extremes of age",
            "Abuse (children and elderly)"
          ],
          "citations": [
            {
              "refId": "sbq-queimaduras-2021"
            }
          ]
        },
        "fisiopatologia": {
          "texto": "Tissue injury with three zones: coagulation (central necrosis), stasis (potentially salvageable), and hyperemia (inflammation). Major burns develop a systemic inflammatory response with increased capillary permeability, edema, and distributive shock.",
          "citations": [
            {
              "refId": "aba-guidelines-2016"
            }
          ]
        },
        "quadroClinico": {
          "sintomasPrincipais": [
            "Pain (variable depending on depth)",
            "Erythema, blisters, or necrosis",
            "Local or generalized edema",
            "Inhalation symptoms (cough, hoarseness, dyspnea)"
          ],
          "sinaisExameFisico": [
            "Appearance of the injury (color, blisters, texture)",
            "Sensitivity to touch",
            "Capillary refill",
            "Signs of airway injury",
            "Distal pulses (circumferential injury)"
          ],
          "formasClinicas": [
            "Thermal burn (flame, contact, scald)",
            "Chemical burn (acid, alkali)",
            "Electrical burn (low or high voltage)",
            "Inhalation injury"
          ],
          "citations": [
            {
              "refId": "sbq-queimaduras-2021"
            }
          ]
        },
        "diagnostico": {
          "criterios": [
            "Depth assessment",
            "Extent calculation (Rule of Nines or palm)",
            "Identification of special areas",
            "Assessment of associated injuries"
          ],
          "diagnosticoDiferencial": [
            "Toxic epidermal necrolysis (TEN)",
            "Stevens-Johnson syndrome",
            "Severe contact dermatitis",
            "Pemphigus/pemphigoid"
          ],
          "examesLaboratoriais": [
            "Complete blood count",
            "Electrolytes, urea, creatinine",
            "Arterial blood gas",
            "Lactate",
            "CK (electrical burn)",
            "Carboxyhemoglobin (inhalation)"
          ],
          "examesImagem": [
            "Chest X-ray",
            "Bronchoscopy (if inhalation suspected)"
          ],
          "citations": [
            {
              "refId": "aba-guidelines-2016"
            }
          ]
        },
        "tratamento": {
          "objetivos": [
            "Hemodynamic resuscitation",
            "Adequate analgesia",
            "Infection prevention",
            "Adequate healing",
            "Functional and aesthetic preservation"
          ],
          "naoFarmacologico": {
            "medidas": [
              "Initial cooling with running water",
              "Dressings with silver sulfadiazine or biological dressings",
              "Surgical debridement when indicated",
              "Escharotomy/fasciotomy if compartment syndrome",
              "Skin grafting in deep burns",
              "Early physiotherapy"
            ],
            "citations": [
              {
                "refId": "sbq-queimaduras-2021"
              }
            ]
          },
          "farmacologico": {
            "primeiraLinha": [
              {
                "classe": "Crystalloid",
                "medicamentos": [
                  "Ringer's Lactate"
                ],
                "posologia": "4mL/kg/%TBSA in 24h (Parkland)",
                "observacoes": "50% in the first 8h"
              },
              {
                "classe": "Analgesic",
                "medicamentos": [
                  "Morphine",
                  "Tramadol"
                ],
                "posologia": "As needed for pain intensity"
              },
              {
                "classe": "Tetanus prophylaxis",
                "medicamentos": [
                  "dT vaccine + TAT if necessary"
                ]
              }
            ],
            "segundaLinha": [
              {
                "classe": "Topical antimicrobial",
                "medicamentos": [
                  "1% Silver sulfadiazine"
                ],
                "observacoes": "In 2nd/3rd degree burns"
              }
            ],
            "citations": [
              {
                "refId": "aba-guidelines-2016"
              }
            ]
          },
          "duracao": "Variable depending on extent and depth"
        },
        "acompanhamento": {
          "frequenciaConsultas": "Dressing changes every 24-72h; prolonged follow-up",
          "metasTerapeuticas": [
            "Healing in 2-3 weeks (superficial 2nd degree)",
            "Prevention of hypertrophic scars",
            "Functional rehabilitation",
            "Psychological support"
          ],
          "criteriosEncaminhamento": [
            "Burn center: >20% TBSA, 3rd degree, face/hands/feet/genitals, electrical, chemical, inhalation",
            "Plastic surgery: scars, contractures",
            "Psychology/Psychiatry"
          ],
          "citations": [
            {
              "refId": "sbq-queimaduras-2021"
            }
          ]
        }
      },
      "protocolos": [
        "queimaduras-atendimento-inicial",
        "parkland-ressuscitacao"
      ],
      "medicamentos": [
        "morfina",
        "sulfadiazina-prata"
      ],
      "calculadoras": [
        "regra-dos-9",
        "parkland"
      ],
      "citations": [
        {
          "refId": "sbq-queimaduras-2021"
        },
        {
          "refId": "aba-guidelines-2016"
        }
      ],
      "lastUpdate": "2024-12-23"
    }
  ]
}